News stories about Mazor Robotics (NASDAQ:MZOR) have trended somewhat positive on Thursday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mazor Robotics earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned headlines about the medical instruments supplier an impact score of 46.1909081372609 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the news stories that may have impacted Accern’s analysis:
- Global Medical Robotic Systems Market is Expected to Witness a CAGR of 16.5% During 2018-2024 (globenewswire.com)
- Global Surgical Robots Market 2018: Medtech SA, Mazor Robotics, THINK Surgical, Medrobotics (exclusivereportage.com)
- Medical device co XACT Robotics raises $5m (globes.co.il)
- Phoenix-area hospital offering breakthrough robotic surgery (azfamily.com)
- The Robotic Surgery Revolution Is Just Getting Started (finance.yahoo.com)
Several equities research analysts recently commented on MZOR shares. Needham & Company LLC downgraded Mazor Robotics from a “hold” rating to an “underperform” rating in a report on Friday, March 16th. Zacks Investment Research downgraded Mazor Robotics from a “buy” rating to a “hold” rating in a report on Wednesday, April 18th. Vetr upgraded Mazor Robotics from a “hold” rating to a “strong-buy” rating and set a $77.50 target price on the stock in a report on Monday, March 19th. Finally, BidaskClub downgraded Mazor Robotics from a “strong-buy” rating to a “buy” rating in a report on Friday, March 23rd. Two research analysts have rated the stock with a sell rating, four have given a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $61.08.
Mazor Robotics (NASDAQ:MZOR) last released its quarterly earnings data on Monday, May 14th. The medical instruments supplier reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. Mazor Robotics had a negative net margin of 12.14% and a negative return on equity of 8.08%. The firm had revenue of $15.51 million for the quarter, compared to analysts’ expectations of $15.13 million. During the same quarter in the previous year, the company earned ($0.08) earnings per share. The company’s revenue for the quarter was up 32.3% compared to the same quarter last year. equities analysts anticipate that Mazor Robotics will post 0.05 earnings per share for the current fiscal year.
About Mazor Robotics
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. The company operates in the field of image guided surgery and computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.